There was a trend toward a reduction in the development of breakthrough HE among patients receiving the probiotic ( @ % in the probiotic group vs @ % in the placebo group ; hazard ratio -LSB- HR -RSB- , @ ; @ % confidence interval -LSB- CI -RSB- , @-@ @ ; P = @ ) .